Treatment of malignant insulinoma with Streptozotocin.
D000141:Acidosis, Renal Tubular / Q000139:chemically induced; D007516:Adenoma, Islet Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000328:Adult; D000606:Amino Sugars / Q000009:adverse effects / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D002445:Celiac Artery; D003919:Diabetes Insipidus / Q000139:chemically induced; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009603:Nitroso Compounds / Q000009:adverse effects / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011859:Radiography
D000606:Amino Sugars; D000903:Antibiotics, Antineoplastic; D009603:Nitroso Compounds